Skip to content
★ Sign in to follow
BS

Bruno Sartori

Nutra Pharma Corp
Total declarations
11
Company
1
▲ Purchases (9 ops.)
€2,183
▼ Sales (1 ops.)
€2,673

Latest filing published 11 Sept 2012 for NUTRA PHARMA CORP, €48.

Insider track record

Disclosed buys
9
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
9
Positive at T+90
0%
Median T+90
-4.0%

Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 11 Sept 2012 · 5171 days ago · €48
    +6.7%
    Entry US$0.60 · Close at T+365 US$0.64

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Bruno Sartori: trading record in brief

This profile gathers the share dealings of Bruno Sartori in Nutra Pharma Corp. The record holds 11 filings, for trades running from 10 February 2012 to 30 August 2012.

Both buying and selling appear: 9 purchases worth €2,183, against 1 sale worth €2,673. Taken together, the sales exceed the purchases by €490. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.

In size, the median ticket on the buying side is €102. For 9 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -4.0%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 11 September 2012, reports an open-market purchase of €48 in Nutra Pharma Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Bruno Sartori

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ▲
    ExecutivesNutra Pharma Corp
    63 USD0SEC
    5,000 shares@ US$0.0125Common StockSEC:0001144204-12-050640:0
    Canonical exit: 22 Jul 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    288 USD0SEC
    25,000 shares@ US$0.0115Common StockSEC:0001144204-12-050640:1
    Canonical exit: 22 Jul 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    135 USD0SEC
    10,000 shares@ US$0.0135Common StockSEC:0001144204-12-050640:2
    Canonical exit: 23 Jul 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    782 USD0SEC
    68,000 shares@ US$0.0115Common StockSEC:0001144204-12-050640:3
    Canonical exit: 24 Jul 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    1,155 USD0SEC
    105,000 shares@ US$0.011Common StockSEC:0001144204-12-050640:4
    Canonical exit: 25 Jul 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    77 USD0SEC
    7,000 shares@ US$0.011Common StockSEC:0001144204-12-050640:5
    Canonical exit: 20 Aug 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    120 USD0SEC
    8,000 shares@ US$0.015Common StockSEC:0001144204-12-050640:6
    Canonical exit: 28 Aug 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    130 USD0SEC
    10,000 shares@ US$0.013Common StockSEC:0001144204-12-050640:7
    Canonical exit: 29 Aug 2012 (T+90)
  • ▲
    ExecutivesNutra Pharma Corp
    105 USD0SEC
    8,100 shares@ US$0.013Common StockSEC:0001144204-12-050640:8
    Canonical exit: 30 Aug 2012 (T+90)
  • ▼
    ExecutivesNutra Pharma Corp
    3,344 USD0SEC
    303,990 shares@ US$0.011Common StockSEC:0001144204-12-050640:9
  • ◆
    ExecutivesNutra Pharma Corp
    0SEC
    240,000 shares0Common StockSEC:0001144204-12-050069:0

11 of 11 declarations